Patent US4199561A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4199561A Expired / Lapsed US ⏱️ 0.0 years remaining

Coated nutrients and medicaments for veterinary use

Assignee: Dow Chemical Co
•
Filing: 1979-02-26
•
Granted: 1980-04-22
•
Expires: 1999-02-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An imidazoline modified styrene-acrylonitrile polymer composition which is substantially insoluble in aqueous media at about pH 6 or more but swellable or soluble at pH 3 or less is employed as a coating for nutrient or therapeutic substances for administration to ruminants. The substances thus are rendered resistant to attack and breakdown in the rumen yet remain susceptible to release and digestion within the abomasum or small intestine of the animal.

Inventors

  • 👤 Harold H. Roth
  • 👤 Peter W. Owen
  • 👤 Thomas T. Chiu

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 12:08
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5026; A23; A23K; A23K40/00; A23K40/30; A23K40/35; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1635; C; C08; C08F; C08F8/00; C08F8/30; C08F8/32; C08F2800/00; C08F2800/20

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 111 words
A nutrient or therapeutic orally administered composition for ruminant animals comprising the composition of a nutrient or therapeutic material and coated thereon an hydroxyethyl imidazoline modified styrene-acrylonitrile polymer composition containing from about 15 to about 35 weight percent polymerized acrylonitrile, from about 85 to about 65 weight percent styrene, having a molecular weight of from about 60,000 to about 200,000, which polymer contains from 14 to 23 mole percent hydroxyethyl imidazoline modification, said combination being of such form that the material is thereby rendered resistant to attack and breakdown within the rumen of the animal but remains susceptible to breakdown and digestion within the abomasum or small intestine of the animal.
Claim 2
Dependent Claim 111 words
A nutrient or therapeutic orally administered composition for ruminant animals comprising the composition of a nutrient or therapeutic material and coated thereon an hydroxyethyl imidazoline modified styrene-acrylonitrile polymer composition containing from about 15 to about 35 weight percent polymerized acrylonitrile, from about 85 to about 65 weight percent styrene, having a molecular weight of from about 60,000 to about 200,000, which polymer contains from 14 to 23 mole percent hydroxyethyl imidazoline modification, said combination being of such form that the material is thereby rendered resistant to attack and breakdown within the rumen of the animal but remains susceptible to breakdown and digestion within the abomasum or small intestine of the animal.
Claim 3
Dependent Claim 30 words
A composition as in claim 1, wherein the nutrient or therapeutic material is in the form of discrete bodies or particles having a substantially continuous surface coating of said polymer.
Claim 4
Dependent Claim 23 words
A composition as in claim 1, wherein the particles of the nutrient or therapeutic material are dispersed throughout a matrix of said polymer.
Claim 5
Dependent Claim 14 words
A composition as in claim 1, wherein said nutrient material is an amino acid.
Claim 6
Dependent Claim 12 words
A composition as in claim 4, wherein said amino acid is methionine.
Claim 7
Dependent Claim 13 words
A composition as in claim 1, wherein said therapeutic material is an antibotic.
Claim 8
Dependent Claim 13 words
A composition as in claim 1, wherein said therapeutic material is an anthelmintic.
Claim 9
Independent Claim 113 words
A method for treating ruminant animals comprising orally administering to the animal a nutrient or therapeutic composition or supplement comprising a combination of a nutrient or a therapeutic material having coated thereon an hydroxyethyl imidazoline modified styrene-acrylonitrile polymer composition containing from about 15 to about 35 weight percent polymerized acrylonitrile, from about 85 to about 65 weight percent styrene, having a molecular weight of from about 60,000 to about 200,000, which polymer contains from 14 to 23 mole percent hydroxyethyl imidazoline modification, the coated product thereby rendered resistant to attack and breakdown within the rumen of the animal while susceptible to breakdown and digestion within the abomasum or small intestine of the animal.
Claim 10
Independent Claim 113 words
A method for treating ruminant animals comprising orally administering to the animal a nutrient or therapeutic composition or supplement comprising a combination of a nutrient or a therapeutic material having coated thereon an hydroxyethyl imidazoline modified styrene-acrylonitrile polymer composition containing from about 15 to about 35 weight percent polymerized acrylonitrile, from about 85 to about 65 weight percent styrene, having a molecular weight of from about 60,000 to about 200,000, which polymer contains from 14 to 23 mole percent hydroxyethyl imidazoline modification, the coated product thereby rendered resistant to attack and breakdown within the rumen of the animal while susceptible to breakdown and digestion within the abomasum or small intestine of the animal.
Claim 11
Dependent Claim 30 words
A method as in claim 8, wherein the nutrient or therapeutic material is in the form of discrete bodies or particles having a substantially continuous surface coating of said polymer.
Claim 12
Dependent Claim 22 words
A method as in claim 8, wherein particles of the nutrient or therapeutic material are dispersed throughout a matrix of said polymer.
Claim 13
Dependent Claim 14 words
A method as in claim 8, wherein said nutrient material is an amino acid.
Claim 14
Dependent Claim 12 words
A method as in claim 11, wherein said amino acid is methionine.
Claim 15
Dependent Claim 13 words
A method as in claim 8, wherein said therapeutic material is an antibotic.
Claim 16
Dependent Claim 13 words
A method as in claim 8, wherein said therapeutic material is an anthelmintic.

References Cited (Backward Citations)

US3477995A Cited
US3453360A Cited
US3619200A Cited
US3553313A Cited
US3764477A Cited
US3803302A Cited
US3829564A Cited
US3766203A Cited
US3919436A Cited
US3968277A Cited
US4001389A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-04-22 1983-10-22 1984-04-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-04-22 1987-10-22 1988-04-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-04-22 1991-10-22 1992-04-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag